Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy, safety and feasibility of
outpatient-utilization of low-dose dasiglucagon administered via a multi-dose reusable pen
injector in preventing and treating mild hypoglycemia in insulin pump-treated people with
type 1 diabetes.